内脏脂肪组织和残留心血管风险:一种病理联系和新的治疗选择
Arturo Cesaro1,2, Gianantonio De Michele1,2, Fabio Fimiani3
1Department of Translational Medical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy.
内脏脂肪组织 (VAT) 积累导致低度炎症,增加心血管疾病 (CVD) 风险. 葡萄糖类1 (GLP-1) 激动剂,如利拉格卢提德,在减少VAT和炎症方面表现有前途,为管理残留心血管疾病风险提供了新的治疗途径.
科学领域:
- 内分泌学 在内分泌学.
- 心脏病学 心脏病学
- 代谢综合征是代谢综合征的一种.
背景情况:
- 肥胖影响全球三分之一的人口,与心血管疾病 (CVD) 有关.
- 心血管风险与脂肪的分布,特别是内脏脂肪组织 (VAT) 的分布更密切相关,而不是总体脂肪.
- 增值税累积有助于低级系统性炎症,显著影响死亡率和心肌梗塞风险.
研究的目的:
- 审查内脏脂肪组织 (VAT) 在残留心血管风险中的作用.
- 讨论治疗策略,以减少与增值税累积相关的残留心血管风险.
- 突出新型肥胖治疗的潜力,特别是GLP-1激动剂,在管理VAT和炎症方面.
主要方法:
- 审查关于肥胖,增值税,心血管风险和治疗干预措施的现有文献.
- 分析增值税导致系统性炎症的机制.
- 评估各种减肥药物的疗效和副作用概况,包括奥利斯塔特,纳尔特雷克松-布罗,利拉格卢提德和西马格卢提德.
主要成果:
- 增值税积累是低级系统性炎症和残留心血管风险的重要驱动因素.
- 虽然有一些减肥药物存在,但它们在耐受性上有局限性或对增值税产生特定影响.
- 类似葡萄糖类1 (GLP-1) 激动剂,如利拉格卢提德和塞马格卢提德,促进显著的体重减轻,并且在糖尿病患者中显示出积极的心血管结果.
- 利拉格卢提德特别表明,在没有糖尿病的肥胖患者中,减少了VAT和炎症标志物.
结论:
- 增值税在通过炎症的残留心血管风险中发挥着关键作用.
- GLP-1激动剂是治疗肥胖相关炎症和降低心血管风险的一个有前途的治疗类.
- 利拉格卢提德在减少增值税和炎症方面表现出特别的有效性,为肥胖患者提供了有针对性的方法.
更多相关视频
08:41Assessment of Vascular Tone Responsiveness using Isolated Mesenteric Arteries with a Focus on Modulation by Perivascular Adipose Tissues
Published on: June 3, 2019
06:22Isolation of Viable Adipocytes and Stromal Vascular Fraction from Human Visceral Adipose Tissue Suitable for RNA Analysis and Macrophage Phenotyping
Published on: October 27, 2020
相关概念视频
Cholesterol: Significance and Regulation
Considering cholesterol and...
Atherosclerosis III: Management
Hypodermis
Exercise and Cardiovascular Response
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Adrenergic Antagonists: ɑ and β-Receptor Blockers
